Contemporary adverse event profile of microsurgery for intracranial unruptured aneurysms in high-volume microsurgical centers: the international PRAEMIUM study

Authors

Victor E. Staartjes, Machine Intelligence in Clinical Neuroscience & Microsurgical Neuroanatomy (MICN) Laboratory, Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.
Alexios A. Adamides, Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Pasquale Anania, Department of Neurosurgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Mustafa K. Baskaya, Department of Neurosurgery, University of Wisconsin, Madison, Wisconsin.
Vladimir Beneš, Department of Neurosurgery, Central Military Hospital, Charles University, Prague, Czech Republic.
Amir R. Dehdashti, Department of Neurosurgery, NorthShore University Hospital, Manhasset, New York.
Antonio Di Ieva, Computational NeuroSurgery (CNS) Laboratory, Macquarie Medical School, Macquarie University, Sydney, New South Wales, Australia.
Paolo Ferroli, Department of Neurosurgery, Istituto Neurologico Carlo Besta, Milan, Italy.
Asgeir S. Jakola, Department of Neurosurgery, Sahlgrenska University Hospital, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.
Giuseppe Lanzino, Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota.
Michael T. Lawton, Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona.
Ondra Petr, Department of Neurosurgery, University Hospital Innsbruck, Austria.
Thomas Petutschnigg, Department of Neurosurgery and Stroke Research Center Bern, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Giampietro Pinna, Department of Neurosurgery, University Hospital Verona, Italy.
Dino Podlesek, Department of Neurosurgery, University Hospital Dresden, Germany.
Ivan Radovanovic, Department of Neurosurgery, Toronto Western Hospital, Toronto, Ontario, Canada.
Veit Rohde, Department of Neurosurgery, University Hospital Göttingen, Germany.
Nico Stroh-Holly, Department of Neurosurgery, Kepler University Hospital, Linz, Austria.
Carmelo Lucio Sturiale, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy; and.
Anthony C. Wang, Department of Neurosurgery, University of California, Los Angeles, California.
Luca Regli, Machine Intelligence in Clinical Neuroscience & Microsurgical Neuroanatomy (MICN) Laboratory, Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.
Giuseppe Esposito, Machine Intelligence in Clinical Neuroscience & Microsurgical Neuroanatomy (MICN) Laboratory, Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Document Type

Article

Abstract

OBJECTIVE: Objective values on procedural risk are essential to facilitate informed consent and optimize clinical decision-making in patients with unruptured intracranial aneurysms (UIAs). While robust heuristics, such as the PHASES (population, hypertension, age, size of aneurysm, earlier subarachnoid hemorrhage, and site of aneurysm) score, are established for predicting rupture risk, contemporary and granular benchmarks for procedural safety remain scarce. The multinational Prediction of Adverse Events After Microsurgery for Intracranial Unruptured Aneurysms (PRAEMIUM) study aims to comprehensively characterize contemporary adverse event rates following microsurgical treatment at high-volume expert centers, stratified by aneurysm location, morphology, and complexity factors to better inform individual risk/benefit analyses. METHODS: A cohort study among 20 participating expert centers from 9 countries was established. Patients treated microsurgically for UIAs were included. The authors describe the epidemiology of treated patients and UIAs and a comprehensive adverse event profile using 3 outcomes measured at hospital discharge: 1) poor neurological outcome (modified Rankin Scale score ≥ 3), 2) new sensorimotor neurological deficits, and 3) all-cause adverse events (Clavien-Dindo grade ≥ 1). Subgroup reports were given for aneurysm location, morphology, and complexity factors (prior aneurysm treatment, calcifications, complex angioanatomy involving critical branch vessels or perforators, and thrombosis). The authors purposely chose discharge as the time point to capture early postoperative risks and complications in patients with asymptomatic UIAs, for whom preserving neurological function is paramount. RESULTS: The cohort included 3705 patients (mean age 56 [SD 12] years, 28% male). Overall, at discharge 13.9% of patients (95% CI 12.8%-15.0%) had poor neurological functional outcomes, 14.4% (95% CI 13.3%-15.5%) had new sensorimotor deficits, and 24.1% (95% CI 22.8%-25.5%) experienced all-cause adverse events. Poor neurological outcomes ranged from 8.5% (M1 aneurysms) to 37.4% (posterior circulation aneurysms), neurological deficits from 9.3% (distal anterior cerebral artery [ACA] aneurysms) to 34.2% (posterior circulation aneurysms), and all-cause adverse events from 21.2% (distal ACA aneurysms) to 31.3% (posterior circulation aneurysms). Dissecting and fusiform aneurysms showed notably high rates of poor neurological outcomes (22.0%-33.3%), new deficits (25.4%-26.7%), and adverse events (26.7%-37.0%). Complexity factors significantly influenced outcomes, with prior treatment (22.9%, 19.7%, and 30.1%), calcification (16.3%, 18.1%, and 30.5%), complex angioanatomy (13.1%, 15.9%, and 26.9%), and thrombosis (19.6%, 23.9%, and 39.6%) notably increasing the risks for poor neurological outcomes, deficits, and adverse events, respectively. CONCLUSIONS: This large international cohort provides contemporary benchmarks for microsurgical treatment of UIAs, emphasizing variability in outcomes based on aneurysm location, morphology, and complexity. The presented granular and quotable adverse event rates support informed patient counseling and individualized risk/benefit assessments in comparable high-volume centers.

Medical Subject Headings

Humans; Intracranial Aneurysm (surgery); Microsurgery (adverse effects, trends); Male; Female; Middle Aged; Aged; Postoperative Complications (epidemiology, etiology); Cohort Studies; Adult; Treatment Outcome; Neurosurgical Procedures (adverse effects); Hospitals, High-Volume

Publication Date

12-1-2025

Publication Title

Neurosurgical focus

E-ISSN

1092-0684

Volume

59

Issue

6

First Page

E18

PubMed ID

41343785

Digital Object Identifier (DOI)

10.3171/2025.9.FOCUS25723

Share

COinS